Evidence map›Paper›PMID 29415882›Full record

ArticleJCI insight2018

Swiprosin-1 deficiency impairs macrophage immune response of septic mice.

Su Zhang, Ye Tu, Yi-Ming Sun, Ya Li, Rong-Mei Wang, Yongbing Cao, Ling Li, Li-Chao Zhang, Zhi-Bin Wang

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
    Article
  14. Article
  15. Article
  16. EF Hand Domain Family Member D2 Is Required for T Cell Cytotoxicity.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Su ZhangCollege of Pharmacy, Second Military Medical University.
Ye TuDepartment of Medicine, Shanghai East Hospital, Tongji University.
Yi-Ming SunCollege of Pharmacy, Second Military Medical University.
Ya LiCollege of Pharmacy, Second Military Medical University.
Rong-Mei WangCollege of Pharmacy, Second Military Medical University.
Yongbing CaoShanghai Institute of Vascular Disease, Shanghai University of Traditional Chinese Medicine, and.
Ling LiShanghai Institute of Vascular Disease, Shanghai University of Traditional Chinese Medicine, and.
Li-Chao ZhangDepartment of Pharmacy, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China.
Zhi-Bin WangCollege of Pharmacy, Second Military Medical University.
Second Military Medical University · CNShanghai University of Traditional Chinese Medicine · CNShanghai East Hospital · CNShanghai Traditional Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the fact that many therapeutic strategies have been adopted to delay the development of sepsis, sepsis remains one of the leading causes of death in noncoronary intensive care units. Recently, sepsis-3 was defined as life-threatening organ dysfunction due to a dysregulated host response to infection. Here, we report that swiprosin-1 (also known as EFhd2) plays an important role in the macrophage immune response to LPS-induced or cecal ligation and puncture-induced (CLP-induced) sepsis in mice. Swiprosin-1 depletion causes higher mortality, more severe organ dysfunction, restrained macrophage recruitment in the lung and kidney, and attenuated inflammatory cytokine production (including IL-1β, IL-6, TNF-α, IL-10, and IFN-γ). The immunosuppression caused by swiprosin-1 deficiency is manifested by impaired bactericidal capacity and decreased HLA-DR expression in macrophages. Swiprosin-1 affects the activation of the JAK2/STAT1/STAT3 pathway by regulating the expression of IFN-γ receptors in macrophages. Our findings provide a potential target for the regulation of the macrophage immune response in sepsis.

Indexed as

AnimalsCalcium-Binding ProteinsCytokinesDisease Models, AnimalEscherichia coliHumansKidneyLipopolysaccharidesLungMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutRAW 264.7 CellsSepsisCalcium-Binding ProteinsCytokinesEFHD2 protein, mouseLipopolysaccharidesCellular immune responseCytokinesImmunologyInfectious diseaseMacrophages

Identifiers

PMID29415882
PMCPMC5821171
OpenAlexW2787464396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.